Medical Marijuana Patients In Germany Get Another Celebrity Offering With Wiz Khalifa’s Cannabis Brand Coming Soon
Khalifa Kush, a cannabis brand founded by multi-platinum-selling, GRAMMY and Golden Globe-nominated recording artist Wiz Khalifa, is coming to Europe. Starting in early 2025, Khalifa Kush will enter the German medical cannabis market through a strategic multi-year partnership with Berlin-based Sanity Group and its leading medical cannabis brand, avaay Medical.
Beginning in January 2025, avvay will introduce two exclusive Khalifa Kush strains in the form of flower as a medical offering to German patients, with additional strain launches to follow throughout the year. Grown under GACP-certified conditions, these strains were specifically produced for the German market by British Columbia cultivator Miracle Valley and processed under EU-GMP standards.
These strains will be available in over 3,000 pharmacies throughout the country for licensed patients.
Exploring More Opportunities In Europe
“I’m excited for our international expansion of Khalifa Kush, as we bring the brand to the European market, starting with Germany,” stated Wiz Khalifa. “When we started exploring …